A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China
Condition(s):LGMD; LGMDR2; LGMDR1Last Updated:October 24, 2023Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):LGMD; LGMDR2; LGMDR1Last Updated:October 24, 2023Enrolling by invitation
Condition(s):Limb-girdle Muscular Dystrophy; Becker Muscular DystrophyLast Updated:September 21, 2023Completed
Condition(s):Neuromuscular Diseases; Limb Girdle Muscular DystrophyLast Updated:November 18, 2023Active, not recruiting
Condition(s):Facioscapulohumeral Muscular Dystrophy; Limb Girdle Muscular DystrophyLast Updated:December 22, 2023Completed
Condition(s):Becker Muscular Dystrophy; McArdle Disease; Limb-Girdle Muscular Dystrophy Type 2Last Updated:October 27, 2022Completed
Condition(s):Muscular Dystrophies; Limb Girdle Muscular DystrophyLast Updated:March 29, 2023Completed
Condition(s):Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2ALast Updated:July 21, 2023Enrolling by invitation
Condition(s):LGMDR9Last Updated:April 6, 2023Recruiting
Condition(s):LGMDLast Updated:August 3, 2023Not yet recruiting
Condition(s):LGMD1B; LGMD1C; LGMD1D; LGMD1E; LGMD1F; LGMD1G; LGMD1H; LGMD2A; LGMD2B; LGMD2C; LGMD2D; LGMD2E; LGMD2F; LGMD2G; LGMD2I; LGMD2J; LGMD2K; LGMD2L; LGMD2M; LGMD2N; LGMD2O; LGMD2P; LGMD2Q; LGMD2S; LGMD2T; LGMD2U; LGMD2W; LGMD2X; LGMD2YLast Updated:February 8, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.